Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology-Reference-Cited by-同舟云学术

Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology

Published:2019-09-03 Issue:10 Volume:58 Page:1333-1336
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Blanchard Pierre¹²³,Aupérin Anne²³,Pignon Jean-Pierre²³

Affiliation:

1. Radiation Oncology Department, Gustave-Roussy, Paris-Saclay University, Villejuif, France;

2. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France;

3. Biostatistics and Epidemiology Department, Gustave-Roussy, Paris-Saclay University, Ligue Nationale Contre le Cancer meta-analysis platform, Villejuif, France

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1649458

Reference35 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

2. Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

3. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

4. Effect of Amifostine on Survival Among Patients Treated With Radiotherapy: A Meta-Analysis of Individual Patient Data

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Pro-Inflammatory Cytokines and Leptin as Potential Biomarkers for Treatment Response and Toxicity in Locally Advanced Squamous Cell Carcinoma of the Head and Neck;Diseases;2024-03-11

2. Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO);Critical Reviews in Oncology/Hematology;2021-06

3. BIGART 2019 – adapting to the future;Acta Oncologica;2019-10-03